Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

HRT 'doubles' women's risk of breast cancer

  • Comment
Another study has found women on HRT have a higher risk of developing breast cancer.

US researchers discovered there was a 28% reduction in risk of breast cancer within one year of stopping HRT treatment with oestrogen and progestin.

The results show women who spend at least five years on HRT double their risk of getting the disease each year.

A previous study by the Women's Health Initiative (WHI) found links between HRT and cancer, blood clots and strokes. This study prompted a 40 million drop in prescriptions for the treatment in the US in 2005.

However, it was argued that the reduction in breast cancer cases was a result of improved mammogram screening.

But Professor Marcia Stefanick, from Stanford University in California, who co-authored the new study, said this new study will confirm that oestrogen plus progestin causes breast cancer.

She said: 'You start women on hormones and within five years, their risk for breast cancer is clearly elevated. You stop the hormones and within one year, their risk is essentially back to normal. It's reasonably convincing cause-and-effect.'

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.